Theratechnologies (Theratechnologies) COGS-to-Revenue : 0.33 (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies COGS-to-Revenue?

Theratechnologies's Cost of Goods Sold for the three months ended in Feb. 2024 was $5.28 Mil. Its Revenue for the three months ended in Feb. 2024 was $16.25 Mil.

Theratechnologies's COGS to Revenue for the three months ended in Feb. 2024 was 0.33.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Theratechnologies's Gross Margin % for the three months ended in Feb. 2024 was 67.48%.

Theratechnologies COGS-to-Revenue Historical Data

The historical data trend for Theratechnologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies COGS-to-Revenue Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

COGS-to-Revenue

Get a 7-Day Free Trial

0.41

0.33

0.24

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
COGS-to-Revenue	Get a 7-Day Free Trial															0.24	0.28	0.24	0.22	0.33

Theratechnologies COGS-to-Revenue Calculation

Theratechnologies's COGS to Revenue for the fiscal year that ended in Nov. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	19.635	/	81.764
	=	0.24

Theratechnologies's COGS to Revenue for the quarter that ended in Feb. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5.284	/	16.247
	=	0.33

Theratechnologies (NAS:THTX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Theratechnologies's Gross Margin % for the three months ended in Feb. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	5.284 / 16.247
	=	67.48 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Theratechnologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Theratechnologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.